Nanobiotix
NBTX
12 hedge funds and large institutions have $46.5M invested in Nanobiotix in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.03% less ownership
Funds ownership: 19.75% → 19.72% (-0.03%)
22% less capital invested
Capital invested by funds: $59.7M → $46.5M (-$13.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$5.3K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.38K |
| 4 |
Barclays
London,
United Kingdom
|
+$663 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$87.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.92K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JJ
1
Johnson & Johnson
New Brunswick,
New Jersey
| $28.1M | – | – | – |
|
2
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $14.3M | – | – | – |
|
|
PA
3
Perceptive Advisors
New York
| $2.78M | – | – | – |
|
|
4
BlackRock
New York
| $1.2M | -$87.1K | -14,446 | -6% |
|
5
UBS Group
Zurich,
Switzerland
| $15.5K | – | – | – |
|
|
GI
6
GAMMA Investing
Foster City,
California
| $10.2K | +$5.3K | +880 | +77% |
|
|
7
Bank of America
Charlotte,
North Carolina
| $3.8K | +$3K | +498 | +190% |
|
|
8
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1.72K | -$1.66K | -276 | -45% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.38K | +229 | +674% |
|
|
10
Barclays
London,
United Kingdom
| $550 | +$663 | +110 | New |
|
11
RhumbLine Advisers
Boston,
Massachusetts
| $165 | – | – | – |
|
12
Morgan Stanley
New York
| $10 | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$2.92K | -450 | Closed |
|
NBTX Hedge Fund Activity: Q2 2024 in Review
12 of the 6,929 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2024, worth a combined $46.5M — down 22% from $59.7M a quarter earlier.
Fund positioning in NBTX was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was GAMMA Investing, adding an estimated $5.3K. The largest seller was BlackRock, cutting an estimated $87.1K.
- 12 institutional investors held Nanobiotix (NBTX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $46.5M of Nanobiotix stock for Q2 2024, down 22% quarter-over-quarter.
- 1 fund opened new Nanobiotix positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Nanobiotix buyer in Q2 2024 was GAMMA Investing, an estimated $5.3K added.
- The largest Nanobiotix seller in Q2 2024 was BlackRock, an estimated $87.1K sold.
Based on aggregated 13F filings for Q2 2024.